FDA formally proposed on April 30, 2026 removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list (Federal Register notice published May 1, 2026: 91 Fed
Improved mental health: Losing weight can also improve mental health outcomes, such as reducing symptoms of depression and anxiety
Healthon will give you facts you can trust and real tips you can use
Understanding risk factors helps you assess your own likelihood and prepare accordingly
How Regulatory Shifts Created the Multi-Billion Dollar Peptide Gray Market The gray market didnt emerge in a vacuum
Allen Mazen Noureddin, MD, MHSc Scott Isaacs, MD, FACP, FACE Scott Isaacs, MD, FACP, FACE Sudhakar Venkatesh Mustafa Bashir Suraj S